Now, it’s worth noting Stock Advisor’s total average return is 983 % — a market-crushing outperformance compared to 195% for ...

ABBV, KO and CVX headline Zacks' top stock reports as analysts flag growth drivers, strategic moves and key headwinds shaping ...

For most drugmakers, the US is the largest single market. Prices there are often close to three times higher than in other ...

Discover the top 10 pharmaceutical stocks of 2025 by YTD performance. See which companies outperformed the sector and get top ...

Novo Nordisk stated only that it was reducing the prices of its highly popular drug in China, although it did not provide ...

Investing.com -- JPMorgan outlined four major large-cap U.S. pharmaceutical stocks it sees performing well in 2026 amid positive regulatory developments and a healthy drug pipeline. JPMorgan said it ...

Discover S&P 500 forecasts for 2025-2026, key market risks, and why pharmaceuticals may outperform. Click for more on my view ...

Nigeria’s listed pharmaceutical companies have quietly delivered some of the strongest equity returns on the Nigerian ...

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is among the ridiculously cheap stocks to buy now. As of December 26, BioMarin ...

Not all growth opportunities require aggressive risk-taking. Investors seeking to build a strong portfolio with steady income ...

Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.

The sharp rise in the share prices pushed the Nifty Pharma index up 0.65 percent to 22,704.30, as seen at 11.15 am on Friday. Earlier during the day, the index gained more than 1.35 percent to 22,863.